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Abstract 
Purpose: Sudden death of a competitive athlete is a tragedy that is 
usually caused by a previously unsuspected
 cardiovascular disease. 
The aim of this study was to clarify the role of noninvasive
 testing 
in pre-participation cardiovascular evaluation of elderly wrestlers. 
Methods: We included 63 Iranian elderly wrestlers who 
participated in Tehran international elderly wrestlers’ preparation 
camping by census method. A questionnaire including past medical 
and family history as well as coronary risk factors was filled out 
and then a complete physical examination of the cardiovascular 
system was done by an internist for all wrestlers. 
Electrocardiogram (ECG), complete echocardiographic 
examination and then symptom limited exercise test were 
performed and reported by the cardiologists who did not know the 
other examinations results. 
Results: Exertional dyspnea and typical chest pain (FC=I or II) 
were present in 5% and 1.7% of the examinees, respectively. There 
were one or more risk factors in 64.5% of the cases. Cardiovascular 
examination revealed abnormal heart sounds in 27.1%. ECG 
showed ischemic changes in 13.6% and premature atrial 
contractions and premature ventricular contractions in 11.4%. 
Echocardiography showed mild left ventricular systolic dysfunction 
in 3.4%, regional wall motion abnormality in 8.5%, valvular 
disease in 32.3%, diastolic dysfunction in 45.7%, and left 
ventricular hypertrophy in 16.9% of the cases. Exercise test results 
were negative, equivocal, positive and highly positive in 70.4%, 
15.8%, 5.2%, and 8.6% of cases, respectively. 
Conclusion: Beside physical examination, pre-participation 
screening of elderly wrestling athletes with ECG and exercise 
testing is feasible and recommended in the presence of coronary 
risk factors or cardiac symptoms. Echocardiography can also be 
recommended to detect other relevant
 abnormalities when there is 
a clue in the standard history, physical examination or ECG. 
    Asian Journal of Sports Medicine, Vol 1 (No 1), March 2010, Pages: 29-34  
 
Farahani AV, et al 
Vol 1, No 1, March 2010 
30 
 
INTRODUCTION 
udden death of a competitive athlete, a tragedy 
usually caused by a previously unsuspected
 
cardiovascular disease, has given rise to several 
programs and panels for pre-participation 
cardiovascular evaluation of athletes all over the 
world
[1-5]. The
 purpose of such screening is to provide 
medical
 clearance for pre-participation in competitive 
sports through routine
  and systematic evaluations 
intended to identify clinically relevant
 and pre-existing 
cardiovascular abnormalities and thereby reducing
 the 
risks associated with organized sports. However, 
detection
 of a possible cardiovascular abnormality on a 
standard screening
  examination is only the first step 
and referral
  to a specialist for further diagnostic 
investigations will probably
  be required. When a 
definitive cardiovascular diagnosis is made,
  a 
consensus panel should recommend participation in
 or 
disqualification from competitive sports. Early 
detection of clinically significant cardiovascular 
diseases
  through pre-participation screening will in 
many instances permit therapeutic interventions that 
may prolong life 
[6]. 
     A variety of cardiovascular abnormalities represent 
the most
  common causes of sudden death in 
competitive athletes. However, lesions differ 
considerably
 with regard to age
[2-5, 7-10]. For example, in 
youthful athletes (younger
 than 35 years), hypertrophic
 
cardiomyopathy is the predominant abnormality in 
about
 one third of cases
[3,4,5]. The next most frequent 
cause in this age group is congenital
  coronary 
anomalies, particularly anomalous origin of the left
 
main coronary artery from the right sinus of 
Valsalva
[11,12]. These deaths occur most commonly in 
team sports such as basketball
 and football, which have 
the highest levels of participation
[6]. 
     Older  athletes  (35  years  and  older)  represent  a 
different athletic
  population because they focus on 
individual endeavors such as
 long-distance running and 
wrestling. A vast majority of deaths in middle-aged
 
athletes is caused by atherosclerotic coronary artery 
disease
[7,8,9, 10]. 
          Sudden cardiac death in athletes is an infrequent
 
event occurring in only a small proportion of 
participants. Indeed, the lesions known to be 
responsible for sudden
 death in younger athletes occur 
infrequently in the general population. These lesions
 
range from relatively common anomalies, such as 
hypertrophic cardiomyopathy
  (1:500) to very rare 
abnormalities such as coronary artery anomalies,
 
arrhythmogenic right ventricular dysplasia, and long 
QT syndrome, for which reliable estimates of 
frequency
  are lacking. Therefore, it is reasonable to 
estimate that congenital
  malformations relevant to 
athletic screening probably account
  for a combined 
prevalence of approximately 0.2% in athletic
 
populations 
[6]. 
     Although the prevalence of athletic field deaths is 
not known with certainty, it appears to be in the range 
of
 1:100,000 to 1:300,000 in high-school-age athletes 
and is
 disproportionately higher in males 
[3,4]. Among 
older athletes,
  available estimates suggest that the 
frequency of sudden
 cardiac death principally due to 
coronary artery disease may
  exceed that of younger 
athletes (1:15,000 in joggers and 1:50,000
 in marathon 
runners) 
[8,13]. 
          In the last decade attention to elderly wrestlers’ 
competitions has increased and several international 
elderly (31 to 50 years old) wrestling competitions took 
place. Currently there are no universally accepted 
standards for the
  pre-participation cardiovascular 
screening of elderly athletes. The aim of this study was 
to classify the role of noninvasive
  testing in pre-
participation cardiovascular evaluation of elderly 
wrestlers. 
METHODS AND SUBJECTS 
In this cross-sectional study which was conducted in 
2006, we recruited all Iranian wrestlers who 
participated in Tehran international elderly wrestlers’ 
preparation camping by census method. We included 
63 male wrestlers in this screening program. Of this, 
four individuals were excluded because of known 
cardiovascular diseases. 
     A questionnaire including complete information on 
past medical and family history as well as coronary risk 
factors was filled out by the subjects. Then a thorough 
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physical examination of cardiovascular system 
including vital signs, heart and lung sounds and 
peripheral vascular exam was conducted by an internist 
for all wrestlers.  
     A 12-lead
 electrocardiogram (ECG) was reported by 
a cardiologist who did not know the wrestlers and their 
history and physical examination results. A complete 
echocardiographic examination was done for all 
wrestlers by a cardiologist, and then a symptom limited 
exercise test was taken in each case and reported by 
another cardiologist.  
          This study was approved by the Research 
Committee of Sports Medicine Research Center and 
Ethics Committee of Tehran University of Medical 
Sciences, Tehran, Iran. 
RESULTS 
The age range of the wrestlers was from 37 to 78 years 
with a mean (±SD) of 54.42 (± 8.64) years. They had a 
history of wrestling from 12 to 55 years with a mean 
(±SD) of 37.76 (± 9.45) years. Fifty five wrestlers 
(93.2%) did not have any cardiovascular symptoms. 
Only three cases (5.1%) had exertional dyspnea and 
one subject (1.7%) had typical chest pain (FC=I or II). 
Twenty one cases (35.5%) did not have any coronary 
risk factors, but there were one or more risk factors in 
others including family history of coronary heart 
disease (25.6%), smoking (22%), hyperlipidemia 
(16.9%), hypertension (11.8%) and diabetes (5%). 
     Following  the  physical  examination,  41  wrestlers 
(69.5%) were found to be completely normal. 
Abnormal findings were detected in 30.5% including 
abnormal heart sounds (27.1%), jugular venous 
distention (3.4%), and abnormal peripheral pulses 
(1.7%). 
     The 12-lead ECG was completely normal in 66.5%. 
Abnormal findings were ischemic changes in 13.6% 
that included pathologic Q wave in 3.4% and T 
inversion in 10.2%. There were premature atrial 
contractions and premature ventricular contractions in 
11.4%, abnormal axis in 3.4%, first-degree 
atrioventricular (AV) block in 3.4%, and abnormal 
rhythm in 1.7% of the cases. 
     Echocardiographic  findings  consisted  of  normal 
ejection fraction (EF > 55%) in 96.6% and mild LV 
systolic dysfunction in 3.4%. Regional wall motion 
abnormality was seen in 8.5% and 91.5% had normal 
wall motion. Valvular study showed 11.9% mild mitral 
regurgitation, 5.1% mild aortic regurgitation, 8.5% 
mild tricuspid regurgitation, 3.4% mild pulmonary 
regurgitation, and 3.4% calcified aortic valve. Doppler 
study of left ventricle showed 45.7% diastolic 
dysfunction (impaired relaxation) and 54.3% normal 
pattern. Left ventricular hypertrophy was reported in 
16.9%, of the cases. 
     Exercise  tests  performed  were  negative  in  70.4%, 
equivocal in 15.8%, positive in 5.2% and highly 
positive in 8.6%. 
DISCUSSION 
Pre-participation cardiovascular screening using   
history taking and physical examination
 alone (without 
noninvasive testing) is not sufficient to guarantee the
 
absence of many critical cardiovascular abnormalities 
in older trained athletes. Indeed, hemodynamically
 
significant congenital aortic valve stenosis is probably 
the
  most likely lesion to be reliably detected during 
routine screening
 because of its characteristically loud 
heart murmur. Detection
  of hypertrophic 
cardiomyopathy by standard screening is unreliable,
 
because most patients have the nonobstructive form of 
this disease,
 characteristically expressed by only a soft 
heart murmur or
  none 
[14,15,16,17]. Furthermore, most 
athletes with hypertrophic
  cardiomyopathy do not 
experience syncope or have a family history
  of 
premature sudden death due to the disease 
[3,18]. 
          The standard history taking and physical 
examination generally conveys low specificity
 for the 
detection of many cardiovascular abnormalities.
  In 
older athletes, however, a personal history of coronary 
risk
 factors can be useful for identifying the individuals 
at risk.
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     The  12-lead  ECG  has  been  proposed  as  a  more
 
practical and cost-effective alternative to routine 
echocardiography
 for population-based screening
 [19,20]. 
Indeed, the ECG is abnormal
  in about 95% of the 
patients with hypertrophic cardiomyopathy 
[21],
 and is 
frequently abnormal in other potentially lethal lesions
 
such as coronary anomalies
  [12], and will usually 
identify the
  important but uncommon long QT 
syndrome 
[22,23]. Recent
  data indicate that a certain 
proportion of genetically affected relatives in families 
with long QT syndrome may have little
  or no 
phenotypic expression on ECG
[22].
  However, these 
problems are not common in older athletes. In pre-
participation screening, ECG is compared unfavorably 
with
 the echocardiogram because of its lack of imaging 
capability
  for recognition of structural cardiovascular 
malformations. ECG also has a relatively low 
specificity as a screening
  test in athletic populations 
because of the high frequency of
 electrocardiographic 
alterations that are associated with normal 
physiological adaptations of an athlete's heart to 
training
[24].
 On the other hand, normal ECG cannot rule 
out coronary artery disease in older athletes. 
          In screening large populations of older trained 
athletes, the routine
  use of exercise testing to detect 
coronary artery disease is
 limited by its low specificity 
and pretest probability
[25]. American College of Sports 
Medicine (ACSM)
  has recommended routine
  use of 
exercise testing for all male athletes over 40, female 
athletes over 50 and athletes with coronary risk factors. 
In athletes over 30 years old, coronary artery disease is 
an important problem, but real possibility of 
myocardial infarction (MI) and sudden cardiac death 
during exercise is low; therefore, the routine
  use of 
exercise testing is not recommended except when there 
is a cardiac symptom such as chest discomfort or when 
there are coronary risk factors
[26]. In a study on 102 
unprofessional football players with an average age of 
45.5 years old, exercise test was positive in 52%
[27]. 
     Echocardiography  can  also  be  expected  to  detect 
other relevant
  abnormalities associated with sudden 
death,
  such as valvular heart disease, aortic root 
dilatation, and
  left ventricular dysfunction (with 
myocarditis and dilated cardiomyopathy) in addition to 
regional wall motion abnormality due to coronary 
artery disease in older athletes.
  However, even such 
diagnostic testing cannot by itself guarantee the
 
identification of all important lesions, and some 
diseases that may not be detectable with any screening 
method
 [28].  
     The potential false-positive or false-negative
 results 
is another important limitation of screening with two-
dimensional
  echocardiography. False-positive results 
may arise from the assignment of
 borderline values for 
left ventricular wall thicknesses (or
 particularly large 
values for cavity size) that require formulation
  of a 
differential diagnosis between the normal physiological
 
adaptations of an athlete's heart
 [29,30,31] and 
pathological
  conditions such as hypertrophic 
cardiomyopathy or other cardiomyopathies 
[33]. In fact, 
such clinical dilemmas (which cannot be definitively
 
resolved in some athletes) generate heavy emotional, 
financial,
  and medical burdens for the athletes, their 
families and the team for
   performing additional 
testing.
  
     Cost-efficiency issues are important in assessing the 
feasibility
  of screening large athletic populations 
[33]. 
There have been relatively few published reports of
 
cardiovascular screening efforts in large older athletic 
populations so far. Most of the studies on athletes have 
implemented noninvasive
 testing (i.e., conventional or 
limited echocardiogram or 12-lead
 ECG) in high school 
or collegiate athletes. We hope that our study helps to 
clarify the role of noninvasive
  testing (12-lead
  ECG, 
echocardiography and exercise testing) in elderly 
athletes. 
CONCLUSION 
Pre-participation cardiovascular screening of elderly 
wrestlers can be started by a standard history taking, 
physical examination and ECG. Then, exercise testing 
is recommended when there is either a cardiac 
symptom such as chest discomfort or when there is a 
coronary risk factor. Echocardiography can also be 
recommended to detect other relevant
  abnormalities 
associated with valvular heart disease, aortic root 
dilatation, and
  left ventricular dysfunction (with  
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myocarditis and dilated cardiomyopathy) as well as 
regional wall motion abnormalities due to CAD when 
there is a clue in the standard history, physical 
examination, or ECG. 
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